Neuralink says it received approval in the U.S. to launch a new feasibility trial for its brain-computer interface (BCI) technology. The new trial evaluates the use of the Elon Musk-backed company’s N1 BCI implant to control an investigational assistive robotic arm. Neuralink claimed in a post on X (the social media platform owned by Musk, […]
Brain-Computer Interface (BCI)
Neuralink gets green light to launch BCI trial in Canada
Neuralink announced that it received approval from Health Canada to launch a study of its brain-computer interface (BCI) system. The Elon Musk-backed BCI maker can now begin the CAN-PRIME study, its first international trial. It evaluates the company’s fully implantable, wireless BCI, building upon the ongoing PRIME study in the U.S. Neuralink said the study […]
Onward receives grant to study BCI in restoring movement after stroke
Onward Medical announced today that it received a grant to study its ARC-BCI therapy to restore upper limb movement after subcortical stroke. The Eindhoven, The Netherlands-based company received the grant from the European Innovation Council (EIC). It can now study the investigational brain-computer interface previously designed to restore lower limb mobility after spinal cord injury […]
BCI developer Precision Neuroscience raises $93M in Series C round
Precision Neuroscience recently closed a $93 million funding round, the brain–computer interface (BCI) developer said in a recent financial disclosure. New York City–based Precision Neuroscience said in the Securities and Exchange Commission filing that it hoped to raise up to $150 million in this latest round, and that 21 unidentified investors took part. The equity […]
Ottobock becomes Onward Medical’s largest shareholder
Ottobock recently announced that it has invested €22.5 million in spinal cord stimulation tech developer Onward Medical. The investment, announced Oct. 24, makes Ottoback (Duderstadt Germany) the largest shareholder in Onward Medical (Eindhoven, The Netherlands). Ottobock’s board chair and owner Hans Georg Näder said: “As the innovation leader in our industry, we see great potential in […]
InBrain Neuroelectronics raises $50M Series B to support BCI
InBrain Neuroelectronics announced today that it closed a Series B financing round with proceeds totaling $50 million. The Barcelona, Spain-based company also secured additional funding and support from Merck KGaA. This goes toward the clinical development of its technology in Merck KGaA’s therapeutic areas of interest. This boosts the translation of the company’s platform to […]
Science Corp. reports positive preliminary clinical data for BCI implant
Brain-computer interface (BCI) developer Science Corporation today announced preliminary clinical trial results for its Prima retina implant. Neuralink co-founder Max Hodak founded Science, which unveiled its Science Eye BCI platform in 2022. The Science Eye is a visual prosthesis that targets retinitis pigmentosa (RP) and dry age-related macular degeneration (AMD), two forms of serious blindness. Science featured […]
Former Medtronic president to become board chair at Onward Medical
Onward Medical announced today that it appointed long-time Medtronic executive Rob ten Hoedt as the new chair of its board of directors. The Eindhoven, The Netherlands-based spinal cord stimulation technology developer plans for ten Hoedt to become chair at year-end. This follows the planned retirement of Jan Ohrstrom, current director and chair, after eight years. […]
Onward licenses BCI technology from CEA
Onward Medical announced today that it signed an exclusive license with CEA to develop and commercialize brain-computer interface (BCI) technology. The license enables Onward to develop and commercialize the investigational WImagine BCI interface designed by CEA. It comes as part of the company’s investigational ARC-BCI system for restoring lower limb mobility after spinal cord injury […]
Analysts see $400B BCI opportunity
Morgan Stanley analysts are betting big on brain-computer interface (BCI) technology as the hype continues to grow around the space. Kallum Titchmarsh, Adam Jonas, Patrick A. Wood, Drew Ranieri, Jakob Dodd, Roberto Valdes Sanchez Navarro and Justin X. Wang of Morgan Stanley recently released a report questioning if BCIs are “The Next Big MedTech Opportunity?” […]
Precision Neuroscience has more positive BCI data
Precision Neuroscience today announced the presentation of results from a pilot study of its brain-computer interface (BCI) technology. Researchers from the lab of Dr. Iahn Cajigas presented results at the Society for Neuroscience (SfN) Neuroscience 2024 conference in Chicago. Cajigas serves as a neurosurgeon at Penn Medicine and an assistant professor of neurosurgery and bioengineering […]
